AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 74 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $598,000 | -11.7% | 65,000 | 0.0% | 0.01% | -22.2% |
| Q4 2016 | $677,000 | +15.1% | 65,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $588,000 | +21.0% | 65,000 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $486,000 | -33.6% | 65,000 | -20.0% | 0.01% | -33.3% |
| Q1 2016 | $732,000 | -41.4% | 81,250 | -15.9% | 0.01% | -47.8% |
| Q4 2015 | $1,249,000 | +33.7% | 96,650 | 0.0% | 0.02% | +15.0% |
| Q3 2015 | $934,000 | -6.1% | 96,650 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $995,000 | +182.7% | 96,650 | +205.4% | 0.02% | +185.7% |
| Q1 2015 | $352,000 | – | 31,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |